XML 23 R12.htm IDEA: XBRL DOCUMENT v3.5.0.2
Marketable Securities
9 Months Ended
Sep. 30, 2016
Investments Debt And Equity Securities [Abstract]  
Marketable Securities

7. Marketable Securities

The Company classifies marketable securities with a remaining maturity when purchased of greater than three months as available-for-sale. Available-for-sale securities may consist of U.S. government agency securities, commercial paper, corporate notes and bonds and certificates of deposit, which are maintained by an investment manager. Available-for-sale securities are carried at fair value, with the unrealized gains and losses included in other comprehensive income (loss) as a component of stockholders’ deficit until realized. The amortized cost of securities in this category is adjusted for amortization of premiums and accretion of discounts to maturity. Realized gains and losses are recognized within interest income.

Cash equivalents and marketable securities as of September 30, 2016 consisted of the following:

 

 

 

September 30, 2016

 

(in thousands)

 

Amortized

Cost

 

 

Unrealized

Gains

 

 

Unrealized

Losses

 

 

Fair

Value

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

32,288

 

 

$

 

 

$

 

 

$

32,288

 

Total cash equivalents

 

$

32,288

 

 

$

 

 

$

 

 

$

32,288

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial paper

 

$

7,000

 

 

$

 

 

$

-

 

 

$

7,000

 

Corporate debt securities

 

 

5,005

 

 

 

 

 

 

(2

)

 

 

5,003

 

Total marketable securities

 

$

12,005

 

 

$

 

 

$

(2

)

 

$

12,003

 

 

As of December 31, 2015, the Company maintained only cash equivalents comprised of money market funds.

 

There were no realized gains or losses on available-for-sale securities during the three or nine months ended September 30, 2016 or 2015. As of September 30, 2016, the Company held three securities that had been in an immaterial unrealized loss position for less than twelve months. The aggregate fair value of these three securities was $12.0 million. As of September 30, 2016, the Company did not intend to sell, and it was not more likely than not that the Company would be required to sell, the securities in an unrealized loss position before recovery of their amortized cost bases. As a result, the Company determined that there was no material change in the credit risk of the investments, and the Company did not hold any securities with an other-than-temporary-impairment as of September 30, 2016.